FDA Puts “Magic Mushrooms” Ingredient On Fast Track For Depression Treatment

Researchers are on a fast track to developing a treatment for depression using the psychedelic compound psilocybin, best known as the active ingredient in so-called “magic mushrooms.”

The U.S. Food and Drug Administration (FDA) recently gave “breakthrough therapy” designation to a psilocybin-based drug being tested by COMPASS Pathways.

That means an accelerated research and approval process for a drug with strong preliminary evidence showing it would be a substantial improvement over currently available therapies.

“The early studies have shown that psilocybin therapy can provide an immediate and sustained reduction in depression following a single treatment,” Tracy Cheung, communications director for COMPASS Pathways, told Healthline. “The effect has been described as psilocybin shaking the brain up like a snow globe, or rebooting the brain, providing new connections and deactivating connections that might have caused depression.”

Source: Healthline.com

Read More Here

Leave a Reply